Niche hijack by malignant cells is considered to be a prominent cause of disease relapse. Barbier and colleagues uncover (E)-selectin as a novel mediator of malignant cell survival and regeneration which, upon blockade, has the potential to significantly improve therapeutic outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378234 | PMC |
http://dx.doi.org/10.1038/s41467-020-17594-7 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!